These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33823471)

  • 61. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy.
    Neutel JM
    Curr Med Res Opin; 2010 Jan; 26(1):213-22. PubMed ID: 19921961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis.
    Darabian S; Luo Y; Homat A; Khosraviani K; Wong N; Zeb I; Nasir K; Budoff MJ
    Coron Artery Dis; 2015 Dec; 26(8):678-85. PubMed ID: 26398149
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
    Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN
    Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study.
    Matsuzawa Y; Ogawa H; Kimura K; Konishi M; Kirigaya J; Fukui K; Tsukahara K; Shimizu H; Iwabuchi K; Yamada Y; Saka K; Takeuchi I; Hirano T; Tamura K
    Hypertens Res; 2020 Nov; 43(11):1257-1266. PubMed ID: 32820236
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Different patterns of one-year evolution of microalbuminuria in hypertensive patients treated with different inhibitors of the renin-angiotensin system.
    Cotter J; Oliveira P; Cunha P; Polónia J
    Rev Port Cardiol; 2008 Nov; 27(11):1395-404. PubMed ID: 19227807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes.
    Al-Sayed NA; Gao T; Wells BJ; Yu C; Zimmerman RS
    Endocr Pract; 2013; 19(4):579-86. PubMed ID: 23425642
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Retrospective Evaluation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Postoperative Estimated Glomerular Filtration Rates Following Robotic-Assisted Partial Nephrectomy.
    Haehn DA; Shumate AM; Bajalia EM; Thomas Ball C; Irizarry-Alvarado JM; Thiel DD
    J Endourol; 2021 Jun; 35(6):808-813. PubMed ID: 33115289
    [No Abstract]   [Full Text] [Related]  

  • 70. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT
    J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.
    Liu CL; Shau WY; Wu CS; Lai MS
    J Hypertens; 2012 Nov; 30(11):2223-9. PubMed ID: 22929610
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
    Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
    J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
    Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
    J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is preoperative chemoradiation in rectal cancer patients modulated by ACE inhibitors? Results from the Dutch Cancer Registry.
    Rombouts AJ; Hugen N; Verhoeven RH; Kuiper JG; Poortmans PM; de Wilt JH; Nagtegaal ID
    Radiother Oncol; 2019 Sep; 138():86-92. PubMed ID: 31252299
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Combination with Angiotensin-Receptor Blockers in Nondiabetic Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Zhao M; Ma S; Yu Y; Wang R; Chang M; Zhang H; Qu H; Zhang Y
    Curr Med Chem; 2021; 28(38):7961-7973. PubMed ID: 34126881
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of the central renin-angiotensin system in Parkinson's disease.
    Mertens B; Vanderheyden P; Michotte Y; Sarre S
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):49-56. PubMed ID: 19861346
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.
    Lin TT; Wu CK; Liao MT; Yang YH; Chen PC; Yeih DF; Lin LY
    PLoS One; 2017; 12(12):e0188720. PubMed ID: 29216228
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T; Amamiya N; Ochi A; Tsuruta Y; Shimizu A; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
    Clin Exp Nephrol; 2011 Oct; 15(5):700-707. PubMed ID: 21625892
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study.
    Jo Y; Kim S; Ye BS; Lee E; Yu YM
    Front Pharmacol; 2022; 13():837890. PubMed ID: 35308220
    [No Abstract]   [Full Text] [Related]  

  • 80. Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination.
    Li J; Mestre TA; Mollenhauer B; Frasier M; Tomlinson JJ; Trenkwalder C; Ramsay T; Manuel D; Schlossmacher MG
    NPJ Parkinsons Dis; 2022 Jul; 8(1):94. PubMed ID: 35906250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.